<DOC>
	<DOCNO>NCT00366080</DOCNO>
	<brief_summary>The purpose study assess effectiveness safety drug GSK189254 treating patient narcolepsy .</brief_summary>
	<brief_title>Effectiveness Of The Drug GSK189254 In Treating Patients With Narcolepsy</brief_title>
	<detailed_description />
	<mesh_term>Narcolepsy</mesh_term>
	<mesh_term>Histamine</mesh_term>
	<mesh_term>Histamine H3 Antagonists</mesh_term>
	<criteria>Inclusion criterion : Narcolepsy patient Body mass index 18 32 kg/m2 Females may child bear nonchild bear potential . Agreement refrain drive operate heavy machinery duration study . Must able withdraw medication treatment daytime sleepiness must live . Exclusion criterion : History presence major psychiatric disorder depression . History significant head trauma previous 12 month . Participation clinical trial previous 3 month . Patient significant recent ( within 1 year ) history drug alcohol abuse . Patient pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>GSK189254 H3 Histamine Narcolepsy</keyword>
</DOC>